Published in
Wiley, British Journal of Dermatology, 3(182), p. 794-797, 2019
DOI: 10.1111/bjd.18559
Links
Tools
EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa
Journal article published in 2019 by
S. Gaucher 
,
S. M. Lwin ,
M. Titeux ,
A. Abdul‐Wahab ,
N. Pironon ,
A. Izmiryan ,
S. Miskinyte ,
C. Ganier ,
S. Duchatelet ,
J. E. Mellerio ,
E. Bourrat ,
J. A. McGrath ,
A. Hovnanian
,
S. M. Lwin ,
M. Titeux ,
A. Abdul‐Wahab ,
N. Pironon ,
A. Izmiryan ,
S. Miskinyte ,
C. Ganier ,
S. Duchatelet ,
J. E. Mellerio ,
E. Bourrat ,
J. A. McGrath ,
A. Hovnanian
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 